SCHEDULE 13G Filed 2026-10-19 Event — SEC 0001493152-26-047551 →

HIRSCHMAN ORIN → Kyverna Therapeutics, Inc. KYTX

Stake: — Shares: — Class: Common Stock, par value $0.00001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

9 filings by this filer

8 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 8.85

9,618,412 shares short · +9.7% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $303K

Point72 Asset Mgmt

Other Filings by HIRSCHMAN ORIN

Filed	Form	Issuer	Stake	Shares
2026-10-19	SCHEDULE 13G	Orion Energy Systems, Inc.	—	—	view →
2026-10-19	SCHEDULE 13G	METHODE ELECTRONICS INC	—	—	view →
2026-10-19	SCHEDULE 13G	AEye, Inc.	—	—	view →
2026-10-19	SCHEDULE 13G	ASPEN AEROGELS, INC.	—	—	view →
2026-10-19	SCHEDULE 13G	Bionano Genomics, Inc.	—	—	view →
2026-10-19	SCHEDULE 13G	EDAP TMS S.A.	—	—	view →
2026-07-27	SCHEDULE 13G	Amtech Systems, Inc.	—	—	view →
2026-06-22	SCHEDULE 13G	NYXOAH SA NYXH	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →